Thymoma staging: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(20 intermediate revisions by 5 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
 
* The thymic epithelial tumor staging system was initially proposed by Bergh and his colleagues in 1978,<ref name="Bergh-1978">{{Cite journal  | last1 = Bergh | first1 = NP. | last2 = Gatzinsky | first2 = P. | last3 = Larsson | first3 = S. | last4 = Lundin | first4 = P. | last5 = Ridell | first5 = B. | title = Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. | journal = Ann Thorac Surg | volume = 25 | issue = 2 | pages = 91-8 | month = Feb | year = 1978 | doi =  | PMID = 626543 }}</ref> modified by Wilkins and Castleman in 1979,<ref name="Wilkins-1979">{{Cite journal  | last1 = Wilkins | first1 = EW. | last2 = Castleman | first2 = B. | title = Thymoma: a continuing survey at the Massachusetts General Hospital. | journal = Ann Thorac Surg | volume = 28 | issue = 3 | pages = 252-6 | month = Sep | year = 1979 | doi =  | PMID = 485626 }}</ref> and further developed by Masaoka et al. in 1981.<ref name="Masaoka-1981">{{Cite journal  | last1 = Masaoka | first1 = A. | last2 = Monden | first2 = Y. | last3 = Nakahara | first3 = K. | last4 = Tanioka | first4 = T. | title = Follow-up study of thymomas with special reference to their clinical stages. | journal = Cancer | volume = 48 | issue = 11 | pages = 2485-92 | month = Dec | year = 1981 | doi =  | PMID = 7296496 }}</ref><ref name="Kondo-2005">{{Cite journal  | last1 = Kondo | first1 = K. | title = Invited commentary. | journal = Ann Thorac Surg | volume = 80 | issue = 6 | pages = 2000-1 | month = Dec | year = 2005 | doi = 10.1016/j.athoracsur.2005.08.053 | PMID = 16305832 }}</ref>  
Staging of thymic epithelial tumors was initially proposed by Bergh and his colleagues in 1978,<ref name="Bergh-1978">{{Cite journal  | last1 = Bergh | first1 = NP. | last2 = Gatzinsky | first2 = P. | last3 = Larsson | first3 = S. | last4 = Lundin | first4 = P. | last5 = Ridell | first5 = B. | title = Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. | journal = Ann Thorac Surg | volume = 25 | issue = 2 | pages = 91-8 | month = Feb | year = 1978 | doi =  | PMID = 626543 }}</ref> modified by Wilkins and Castleman in 1979,<ref name="Wilkins-1979">{{Cite journal  | last1 = Wilkins | first1 = EW. | last2 = Castleman | first2 = B. | title = Thymoma: a continuing survey at the Massachusetts General Hospital. | journal = Ann Thorac Surg | volume = 28 | issue = 3 | pages = 252-6 | month = Sep | year = 1979 | doi =  | PMID = 485626 }}</ref> and advanced by Masaoka et al. in 1981.<ref name="Masaoka-1981">{{Cite journal  | last1 = Masaoka | first1 = A. | last2 = Monden | first2 = Y. | last3 = Nakahara | first3 = K. | last4 = Tanioka | first4 = T. | title = Follow-up study of thymomas with special reference to their clinical stages. | journal = Cancer | volume = 48 | issue = 11 | pages = 2485-92 | month = Dec | year = 1981 | doi =  | PMID = 7296496 }}</ref><ref name="Kondo-2005">{{Cite journal  | last1 = Kondo | first1 = K. | title = Invited commentary. | journal = Ann Thorac Surg | volume = 80 | issue = 6 | pages = 2000-1 | month = Dec | year = 2005 | doi = 10.1016/j.athoracsur.2005.08.053 | PMID = 16305832 }}</ref> Modified Masaoka staging grouped with TNM classification is the most widely adopted system for thymic epithelial tumors currently in use.
* Modified Masaoka staging grouped with TNM classification is the most widely adopted system for thymic epithelial tumors currently in use.


==Modified Masaoka Clinical Staging of Thymoma==
==Modified Masaoka Clinical Staging of Thymoma==


 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 2px solid #696969;" align="center"
|+ <SMALL>''Modified Masaoka Clinical Staging of Thymoma (1994)''<ref name="Masaoka-1994">{{Cite journal  | last1 = Masaoka | first1 = A. | last2 = Yamakawa | first2 = Y. | last3 = Niwa | first3 = H. | last4 = Fukai | first4 = I. | last5 = Saito | first5 = Y. | last6 = Tokudome | first6 = S. | last7 = Nakahara | first7 = K. | last8 = Fujii | first8 = Y. | title = Thymectomy and malignancy. | journal = Eur J Cardiothorac Surg | volume = 8 | issue = 5 | pages = 251-3 | month =  | year = 1994 | doi =  | PMID = 8043287 }}</ref></SMALL>
|+ <SMALL>''Modified Masaoka Clinical Staging of Thymoma (1994)''<ref name="Masaoka-1994">{{Cite journal  | last1 = Masaoka | first1 = A. | last2 = Yamakawa | first2 = Y. | last3 = Niwa | first3 = H. | last4 = Fukai | first4 = I. | last5 = Saito | first5 = Y. | last6 = Tokudome | first6 = S. | last7 = Nakahara | first7 = K. | last8 = Fujii | first8 = Y. | title = Thymectomy and malignancy. | journal = Eur J Cardiothorac Surg | volume = 8 | issue = 5 | pages = 251-3 | month =  | year = 1994 | doi =  | PMID = 8043287 }}</ref></SMALL>
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 15px;" | '''Stage'''
! style="background: #4479BA; color:#FFF;" | '''Stage'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 600px;" | '''Description'''
! style="background: #4479BA; color:#FFF;" | '''Description'''
|-
|-
| style="background: #F0F0F0;" align=center | '''I''' || Macroscopically and microscopically completely encapsulated
| style="background: #F0F0F0;" align="center" | '''I'''  
| style="background: #F0F0F0;" | Macroscopically and microscopically completely encapsulated
|-
|-
| style="background: #F0F0F0;" align=center | '''II''' || A. Microscopic transcapsular invasion <BR> B. Macroscopic invasion into surrounding fatty tissue or grossly adherent to but not through <BR> mediastinal pleura or pericardium
| style="background: #F0F0F0;" align="center" | '''II'''  
| style="background: #F0F0F0;" | A. Microscopic transcapsular invasion <BR> B. Macroscopic invasion into surrounding fatty tissue or grossly adherent to but not through <BR> mediastinal pleura or pericardium
|-
|-
| style="background: #F0F0F0;" align=center | '''III''' || Macroscopic invasion into neighboring organs (ie, pericardium, great vessels, lung) <BR> A. Without invasion of great vessels <BR> B. With invasion of great vessels
| style="background: #F0F0F0;" align="center" | '''III'''  
| style="background: #F0F0F0;" | Macroscopic invasion into neighboring organs (ie, pericardium, great vessels, lung) <BR> A. Without invasion of great vessels <BR> B. With invasion of great vessels
|-
|-
| style="background: #F0F0F0;" align=center | '''IV''' || A. Pleural or pericardial dissemination <BR> B. Lymphogenous or hematogenous metastasis
| style="background: #F0F0F0;" align="center" | '''IV'''  
| style="background: #F0F0F0;" | A. Pleural or pericardial dissemination <BR> B. Lymphogenous or hematogenous metastasis
|-
|-
|}
|}


==TNM Classification of Thymic Epithelial Tumors==
==TNM Classification of Thymic Epithelial Tumors==


 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 2px solid #696969;" align="center"
|+ <SMALL>''TNM Classification of Thymic Epithelial Tumors by Yamakawa and Masaoka (1991)''<ref name="pmid3621939">{{cite journal| author=Sinha Hikim AP, Hoffer AP| title=Quantitative analysis of germ cells and Leydig cells in rat made infertile with gossypol. | journal=Contraception | year= 1987 | volume= 35 | issue= 4 | pages= 395-408 | pmid=3621939 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3621939 }} </ref></SMALL>
|+ <SMALL>''TNM Classification of Thymic Epithelial Tumors by Yamakawa and Masaoka (1991)''<ref name="Yamakawa-1991">{{Cite journal | last1 = Yamakawa | first1 = Y. | last2 = Masaoka | first2 = A. | last3 = Hashimoto | first3 = T. | last4 = Niwa | first4 = H. | last5 = Mizuno | first5 = T. | last6 = Fujii | first6 = Y. | last7 = Nakahara | first7 = K. | title = A tentative tumor-node-metastasis classification of thymoma. | journal = Cancer | volume = 68 | issue = 9 | pages = 1984-7 | month = Nov | year = 1991 | doi | PMID = 1913546 }}</ref></SMALL>
! colspan="2" style="background: #4479BA; color:#FFF;" | '''T/N/M Stage'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px;" colspan=2 | '''T/N/M Stage'''
! style="background: #4479BA; color:#FFF;" | '''Description'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 520px;" | '''Description'''
|-
|-
| style="background: #F0F0F0; width:75px;" rowspan=4 align=center | '''T factor''' || style="background: #F0F0F0; width: 50px;" align=center | '''T1''' || Macroscopically completely encapsulated and microscopically no capsular invasion
| rowspan="4" style="background: #F0F0F0; width:75px;" align="center" | '''T factor''' || style="background: #F0F0F0; width: 50px;" align="center" | '''T1'''  
| style="background: #F0F0F0;" | Macroscopically completely encapsulated and microscopically no capsular invasion
|-
|-
| style="background: #F0F0F0;" align=center | '''T2''' || Macroscopically adhesion or invasion into surrounding fatty tissue or mediastinal pleura, <BR> or microscopic invasion into capsule
| style="background: #F0F0F0;" align="center" | '''T2'''  
| style="background: #F0F0F0;" | Macroscopically adhesion or invasion into surrounding fatty tissue or mediastinal pleura, <BR> or microscopic invasion into capsule
|-
|-
| style="background: #F0F0F0;" align=center | '''T3''' || Invasion into neighboring organs, such as pericardium, great vessels, and lung
| style="background: #F0F0F0;" align="center" | '''T3'''  
| style="background: #F0F0F0;" | Invasion into neighboring organs, such as pericardium, great vessels, and lung
|-
|-
| style="background: #F0F0F0;" align=center | '''T4''' || Pleural or pericardial dissemination
| style="background: #F0F0F0;" align="center" | '''T4'''  
| style="background: #F0F0F0;" | Pleural or pericardial dissemination
|-
|-
| style="background: #F0F0F0;" rowspan=4 align=center | '''N factor''' || style="background: #F0F0F0;" align=center | '''N0''' || No lymph node metastasis
| rowspan="4" style="background: #F0F0F0;" align="center" | '''N factor''' || style="background: #F0F0F0;" align="center" | '''N0'''  
| style="background: #F0F0F0;" | No lymph node metastasis
|-
|-
| style="background: #F0F0F0;" align=center | '''N1''' || Metastasis to anterior mediastinal lymph nodes
| style="background: #F0F0F0;" align="center" | '''N1'''  
| style="background: #F0F0F0;" | Metastasis to anterior mediastinal lymph nodes
|-
|-
| style="background: #F0F0F0;" align=center | '''N2''' || Metastasis to intrathoracic lymphnodes except anterior mediastinal lymph nodes
| style="background: #F0F0F0;" align="center" | '''N2'''  
| style="background: #F0F0F0;" | Metastasis to intrathoracic lymphnodes except anterior mediastinal lymph nodes
|-
|-
| style="background: #F0F0F0;" align=center | '''N3''' || Metastasis to extrathoracic lymphnodes
| style="background: #F0F0F0;" align="center" | '''N3'''  
| style="background: #F0F0F0;" | Metastasis to extrathoracic lymphnodes
|-
|-
| style="background: #F0F0F0;" style="background: #F0F0F0;" rowspan=4 align=center | '''M factor''' || style="background: #F0F0F0;" align=center | '''M0''' || No hematogenous metastasis
| rowspan="4" style="background: #F0F0F0;" align="center" | '''M factor''' || style="background: #F0F0F0;" align="center" | '''M0'''  
| style="background: #F0F0F0;" | No hematogenous metastasis
|-
|-
| style="background: #F0F0F0;" align=center | '''M1''' || Hematogenous metastasis
| style="background: #F0F0F0;" align="center" | '''M1'''  
| style="background: #F0F0F0;" | Hematogenous metastasis
|-
|-
|}
|}


 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 2px solid #696969;" align="center"
|+ <SMALL>''Combined Masaoka Staging/TNM Classification (1994)''<ref name="pmid7921194">{{cite journal| author=Tsuchiya R, Koga K, Matsuno Y, Mukai K, Shimosato Y| title=Thymic carcinoma: proposal for pathological TNM and staging. | journal=Pathol Int | year= 1994 | volume= 44 | issue= 7 | pages= 505-12 | pmid=7921194 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7921194 }} </ref></SMALL>
|+ <SMALL>''Combined Masaoka Staging/TNM Classification (1994)''<ref name="Tsuchiya-1994">{{Cite journal | last1 = Tsuchiya | first1 = R. | last2 = Koga | first2 = K. | last3 = Matsuno | first3 = Y. | last4 = Mukai | first4 = K. | last5 = Shimosato | first5 = Y. | title = Thymic carcinoma: proposal for pathological TNM and staging. | journal = Pathol Int | volume = 44 | issue = 7 | pages = 505-12 | month = Jul | year = 1994 | doi = | PMID = 7921194 }}</ref></SMALL>
! style="background: #4479BA; color:#FFF;" | '''Masaoka Stage'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 150px;" | '''Masaoka Stage'''
! style="background: #4479BA; color:#FFF;" | '''T factor'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 150px;" | '''T factor'''
! style="background: #4479BA; color:#FFF;" | '''N factor'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 150px;" | '''N factor'''
! style="background: #4479BA; color:#FFF;" | '''M factor'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 150px;" | '''M factor'''
|-
|-
| style="background: #F0F0F0;" align=center | '''Stage I''' ||align=center| T1 ||align=center| N0 ||align=center| M0
| style="background: #F0F0F0;" align="center" | '''Stage I'''  
| style="background: #F0F0F0;" align="center" | T1  
| style="background: #F0F0F0;" align="center" | N0  
| style="background: #F0F0F0;" align="center" | M0
|-
|-
| style="background: #F0F0F0;" align=center | '''Stage II''' ||align=center| T2 ||align=center| N0 ||align=center| M0
| style="background: #F0F0F0;" align="center" | '''Stage II'''  
| style="background: #F0F0F0;" align="center" | T2  
| style="background: #F0F0F0;" align="center" | N0  
| style="background: #F0F0F0;" align="center" | M0
|-
|-
| style="background: #F0F0F0;" align=center | '''Stage III''' ||align=center| T3 ||align=center| N0 ||align=center| M0
| style="background: #F0F0F0;" align="center" | '''Stage III'''  
| style="background: #F0F0F0;" align="center" | T3  
| style="background: #F0F0F0;" align="center" | N0  
| style="background: #F0F0F0;" align="center" | M0
|-
|-
| style="background: #F0F0F0;" align=center | '''Stage IVa''' ||align=center| T4 ||align=center| N0 ||align=center| M0
| style="background: #F0F0F0;" align="center" | '''Stage IVa'''  
| style="background: #F0F0F0;" align="center" | T4  
| style="background: #F0F0F0;" align="center" | N0  
| style="background: #F0F0F0;" align="center" | M0
|-
|-
| style="background: #F0F0F0;" align=center rowspan=2 | '''Stage IVb''' ||align=center| Any T ||align=center| N1, N2, or N3 ||align=center| M0
| rowspan="2" style="background: #F0F0F0;" align="center" | '''Stage IVb'''  
| style="background: #F0F0F0;" align="center" | Any T  
| style="background: #F0F0F0;" align="center" | N1, N2, or N3  
| style="background: #F0F0F0;" align="center" | M0
|-
|-
|align=center| Any T ||align=center| Any N ||align=center| M1
| style="background: #F0F0F0;" align="center" | Any T  
| style="background: #F0F0F0;" align="center" | Any N  
| style="background: #F0F0F0;" align="center" | M1
|-
|-
|}
|}


==Previously Reported Staging System==
==Previously Reported Staging System==


 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 2px solid #696969;" align="center"
|+ <SMALL>''Masaoka Staging (1981)''<ref name="Masaoka-1981">{{Cite journal  | last1 = Masaoka | first1 = A. | last2 = Monden | first2 = Y. | last3 = Nakahara | first3 = K. | last4 = Tanioka | first4 = T. | title = Follow-up study of thymomas with special reference to their clinical stages. | journal = Cancer | volume = 48 | issue = 11 | pages = 2485-92 | month = Dec | year = 1981 | doi =  | PMID = 7296496 }}</ref></SMALL>
|+ <SMALL>''Masaoka Staging (1981)''<ref name="Masaoka-1981">{{Cite journal  | last1 = Masaoka | first1 = A. | last2 = Monden | first2 = Y. | last3 = Nakahara | first3 = K. | last4 = Tanioka | first4 = T. | title = Follow-up study of thymomas with special reference to their clinical stages. | journal = Cancer | volume = 48 | issue = 11 | pages = 2485-92 | month = Dec | year = 1981 | doi =  | PMID = 7296496 }}</ref></SMALL>
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 15px;" | '''Stage'''
! style="background: #4479BA; color:#FFF;" | '''Stage'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 600px;" | '''Description'''
! style="background: #4479BA; color:#FFF;" | '''Description'''
|-
|-
| style="background: #F0F0F0;" align=center | '''I''' || Macroscopically completely encapsulated and microscopically no capsular invasion
| style="background: #F0F0F0;" align="center" | '''I'''
| style="background: #F0F0F0;" | Macroscopically completely encapsulated and microscopically no capsular invasion
|-
|-
| style="background: #F0F0F0;" align=center | '''II''' || 1. Macroscopic invasion into surrounding fatty tissue or mediastinal pleura <BR> 2. Microscopic invasion into capsule
| style="background: #F0F0F0;" align="center" | '''II'''  
| style="background: #F0F0F0;" | 1. Macroscopic invasion into surrounding fatty tissue or mediastinal pleura <BR> 2. Microscopic invasion into capsule
|-
|-
| style="background: #F0F0F0;" align=center | '''III''' || Macroscopic invasion into neighboring organ (ie, pericardium, great vessels, or lung)
| style="background: #F0F0F0;" align="center" | '''III'''  
| style="background: #F0F0F0;" | Macroscopic invasion into neighboring organ (ie, pericardium, great vessels, or lung)
|-
|-
| style="background: #F0F0F0;" align=center | '''IVa''' || Pleural or pericardial dissemination
| style="background: #F0F0F0;" align="center" | '''IVa'''  
| style="background: #F0F0F0;" | Pleural or pericardial dissemination
|-
|-
| style="background: #F0F0F0;" align=center | '''IVb''' || Lymphogenous or hematogenous metastasis
| style="background: #F0F0F0;" align="center" | '''IVb'''  
| style="background: #F0F0F0;" | Lymphogenous or hematogenous metastasis
|-
|-
|}
|}


 
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
{| style="border: 2px solid #696969;" align="center"
|+ <SMALL>''Clinical Staging by Bergh (1978) and Wilkins (1979)''<ref name="Bergh-1978">{{Cite journal  | last1 = Bergh | first1 = NP. | last2 = Gatzinsky | first2 = P. | last3 = Larsson | first3 = S. | last4 = Lundin | first4 = P. | last5 = Ridell | first5 = B. | title = Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. | journal = Ann Thorac Surg | volume = 25 | issue = 2 | pages = 91-8 | month = Feb | year = 1978 | doi =  | PMID = 626543 }}</ref><ref name="Wilkins-1979">{{Cite journal  | last1 = Wilkins | first1 = EW. | last2 = Castleman | first2 = B. | title = Thymoma: a continuing survey at the Massachusetts General Hospital. | journal = Ann Thorac Surg | volume = 28 | issue = 3 | pages = 252-6 | month = Sep | year = 1979 | doi =  | PMID = 485626 }}</ref></SMALL>
|+ <SMALL>''Clinical Staging by Bergh (1978) and Wilkins (1979)''<ref name="Bergh-1978">{{Cite journal  | last1 = Bergh | first1 = NP. | last2 = Gatzinsky | first2 = P. | last3 = Larsson | first3 = S. | last4 = Lundin | first4 = P. | last5 = Ridell | first5 = B. | title = Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. | journal = Ann Thorac Surg | volume = 25 | issue = 2 | pages = 91-8 | month = Feb | year = 1978 | doi =  | PMID = 626543 }}</ref><ref name="Wilkins-1979">{{Cite journal  | last1 = Wilkins | first1 = EW. | last2 = Castleman | first2 = B. | title = Thymoma: a continuing survey at the Massachusetts General Hospital. | journal = Ann Thorac Surg | volume = 28 | issue = 3 | pages = 252-6 | month = Sep | year = 1979 | doi =  | PMID = 485626 }}</ref></SMALL>
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 100px;" | '''Author'''
! style="background: #4479BA; color:#FFF;" | '''Author'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 15px;" | '''Stage'''
! style="background: #4479BA; color:#FFF;" | '''Stage'''
! style="background: #F0F0F0; border: 0px solid #696969; padding: 0 5px; width: 500px;" | '''Description'''
! style="background: #4479BA; color:#FFF;" | '''Description'''
|-
|-
| style="background: #F0F0F0;" rowspan=3 align=center | Bergh et al. || style="background: #F0F0F0;" align=center | '''I''' || Intact capsule or growth within the capsule
| rowspan="3" style="background: #F0F0F0;" align="center" | Bergh et al. || style="background: #F0F0F0;" align="center" | '''I''' || Intact capsule or growth within the capsule
|-
|-
| style="background: #F0F0F0;" align=center | '''II''' || Pericapsular growth into the mediastinal fat tissue
| style="background: #F0F0F0;" align="center" | '''II''' || Pericapsular growth into the mediastinal fat tissue
|-
|-
| style="background: #F0F0F0;" align=center | '''III''' || Invasive growth into the surrounding organs and/or intrathoracic metastases
| style="background: #F0F0F0;" align="center" | '''III''' || Invasive growth into the surrounding organs and/or intrathoracic metastases
|-
|-
| style="background: #F0F0F0;" rowspan=3 align=center | Wilkins et al. || style="background: #F0F0F0;" align=center | '''I''' || Intact capsule or growth within the capsule
| rowspan="3" style="background: #F0F0F0;" align="center" | Wilkins et al. || style="background: #F0F0F0;" align="center" | '''I''' || Intact capsule or growth within the capsule
|-
|-
| style="background: #F0F0F0;" align=center | '''II''' || Pericapsular growth into the mediastinal fat tissue or adjacent pleura or pericardium
| style="background: #F0F0F0;" align="center" | '''II''' || Pericapsular growth into the mediastinal fat tissue or adjacent pleura or pericardium
|-
|-
| style="background: #F0F0F0;" align=center | '''III''' || Invasive growth into the surrounding organs and/or intrathoracic metastases
| style="background: #F0F0F0;" align="center" | '''III''' || Invasive growth into the surrounding organs and/or intrathoracic metastases
|-
|-
|}
|}


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Oncology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Rare diseases]]
[[Category:Rare diseases]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]
[[Category:Surgery]]

Latest revision as of 20:52, 20 November 2018

Thymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thymoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thymoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymoma staging

CDC on Thymoma staging

Thymoma staging in the news

Blogs on Thymoma staging

Directions to Hospitals Treating Thymoma

Risk calculators and risk factors for Thymoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2]

Overview

  • The thymic epithelial tumor staging system was initially proposed by Bergh and his colleagues in 1978,[1] modified by Wilkins and Castleman in 1979,[2] and further developed by Masaoka et al. in 1981.[3][4]
  • Modified Masaoka staging grouped with TNM classification is the most widely adopted system for thymic epithelial tumors currently in use.

Modified Masaoka Clinical Staging of Thymoma

Modified Masaoka Clinical Staging of Thymoma (1994)[5]
Stage Description
I Macroscopically and microscopically completely encapsulated
II A. Microscopic transcapsular invasion
B. Macroscopic invasion into surrounding fatty tissue or grossly adherent to but not through
mediastinal pleura or pericardium
III Macroscopic invasion into neighboring organs (ie, pericardium, great vessels, lung)
A. Without invasion of great vessels
B. With invasion of great vessels
IV A. Pleural or pericardial dissemination
B. Lymphogenous or hematogenous metastasis

TNM Classification of Thymic Epithelial Tumors

TNM Classification of Thymic Epithelial Tumors by Yamakawa and Masaoka (1991)[6]
T/N/M Stage Description
T factor T1 Macroscopically completely encapsulated and microscopically no capsular invasion
T2 Macroscopically adhesion or invasion into surrounding fatty tissue or mediastinal pleura,
or microscopic invasion into capsule
T3 Invasion into neighboring organs, such as pericardium, great vessels, and lung
T4 Pleural or pericardial dissemination
N factor N0 No lymph node metastasis
N1 Metastasis to anterior mediastinal lymph nodes
N2 Metastasis to intrathoracic lymphnodes except anterior mediastinal lymph nodes
N3 Metastasis to extrathoracic lymphnodes
M factor M0 No hematogenous metastasis
M1 Hematogenous metastasis
Combined Masaoka Staging/TNM Classification (1994)[7]
Masaoka Stage T factor N factor M factor
Stage I T1 N0 M0
Stage II T2 N0 M0
Stage III T3 N0 M0
Stage IVa T4 N0 M0
Stage IVb Any T N1, N2, or N3 M0
Any T Any N M1

Previously Reported Staging System

Masaoka Staging (1981)[3]
Stage Description
I Macroscopically completely encapsulated and microscopically no capsular invasion
II 1. Macroscopic invasion into surrounding fatty tissue or mediastinal pleura
2. Microscopic invasion into capsule
III Macroscopic invasion into neighboring organ (ie, pericardium, great vessels, or lung)
IVa Pleural or pericardial dissemination
IVb Lymphogenous or hematogenous metastasis
Clinical Staging by Bergh (1978) and Wilkins (1979)[1][2]
Author Stage Description
Bergh et al. I Intact capsule or growth within the capsule
II Pericapsular growth into the mediastinal fat tissue
III Invasive growth into the surrounding organs and/or intrathoracic metastases
Wilkins et al. I Intact capsule or growth within the capsule
II Pericapsular growth into the mediastinal fat tissue or adjacent pleura or pericardium
III Invasive growth into the surrounding organs and/or intrathoracic metastases

References

  1. 1.0 1.1 Bergh, NP.; Gatzinsky, P.; Larsson, S.; Lundin, P.; Ridell, B. (1978). "Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas". Ann Thorac Surg. 25 (2): 91–8. PMID 626543. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 Wilkins, EW.; Castleman, B. (1979). "Thymoma: a continuing survey at the Massachusetts General Hospital". Ann Thorac Surg. 28 (3): 252–6. PMID 485626. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Masaoka, A.; Monden, Y.; Nakahara, K.; Tanioka, T. (1981). "Follow-up study of thymomas with special reference to their clinical stages". Cancer. 48 (11): 2485–92. PMID 7296496. Unknown parameter |month= ignored (help)
  4. Kondo, K. (2005). "Invited commentary". Ann Thorac Surg. 80 (6): 2000–1. doi:10.1016/j.athoracsur.2005.08.053. PMID 16305832. Unknown parameter |month= ignored (help)
  5. Masaoka, A.; Yamakawa, Y.; Niwa, H.; Fukai, I.; Saito, Y.; Tokudome, S.; Nakahara, K.; Fujii, Y. (1994). "Thymectomy and malignancy". Eur J Cardiothorac Surg. 8 (5): 251–3. PMID 8043287.
  6. Sinha Hikim AP, Hoffer AP (1987). "Quantitative analysis of germ cells and Leydig cells in rat made infertile with gossypol". Contraception. 35 (4): 395–408. PMID 3621939.
  7. Tsuchiya R, Koga K, Matsuno Y, Mukai K, Shimosato Y (1994). "Thymic carcinoma: proposal for pathological TNM and staging". Pathol Int. 44 (7): 505–12. PMID 7921194.